PATH vs SSII · P/E 19, rev $1.61B vs rev $20.6M
Uipath Inc (PATH) versus SS Innovations International Inc. Common Stock (SSII) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
SS Innovations International Inc. Common Stock (SSII) is a medical devices company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported SSII revenue for 2024-12-31 was $20.6M. Net income was -$19.2M. Revenue was up 251.5% from 2023-12-31 to 2024-12-31. SSII currently screens at market cap $658.4M.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. SSII currently screens at market cap $658.4M.
Not investment advice. Open the PATH and SSII stock pages for the full models.
Not investment advice.